Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6271-6279
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6271
Table 1 Correlation between NADPH oxidase 2 expression and clinical-pathological characters in gastric cancer n (%)
Clinical featureTotal number (n = 123)NOX2 positivity negativityχ2-valueP-value
Gender
Male6930 (43.5)0.8520.229
39 (56.5)
Female5428 (51.9)
26 (48.1)
Age (yr)
< 595527 (49.1)0.1500.419
28 (50.9)
≥ 596831 (45.6)
37 (54.4)
Position
Cardia and fundus308 (26.6)6.6830.008
22 (73.3)
Body and antrum9350 (53.8)
43 (46.2)
Differentiation type
High226 (27.3)5.0620.042
16 (72.7)
Moderate3416 (47.1)
18 (52.9)
Poor6234 (54.8)
28 (45.2)
Undifferentiation52 (40)
3 (60)
Lymph node metastasis
Yes5334 (64.2)10.7960.001
19 (35.8)
No7024 (34.3)
46 (65.7)
Vascular invasion
Yes6035 (58.3)5.8750.012
25 (41.7)
No6323 (36.5)
40 (63.5)
Clinical stage
Early stage329(28.1)6.2850.010
23(71.9)
Advanced stage9149(53.8)
42(46.2)
TNM
I + II3510(28.6)6.7790.008
25(71.4)
III + IV8848(68.6)
40(31.4)
Table 2 Univariate analysis of clinicopathological features for the prognosis in 123 gastric cancer patients
VariableCoefSEWaldRR value (95%CI)P-value
Clinical stage0.5310.2215.79701.701 (1.104-2.620)0.016
Differentiation type0.3630.1933.52501.438 (0.984-2.101)0.060
Lymph node metastasis0.9710.21320.8570.379 (0.250-0.575)0.000
Vascular invasion0.9260.19821.8540.396 (0.269-0.584)0.000
TNM0.6380.2148.90301.892 (1.245-2.876)0.003
NOX21.0800.21226.0040.339 (0.224-0.514)0.000
Table 3 Multivariate analysis of clinicopathological features for the prognosis in 123 gastric cancer patients
VariableCoefSEWaldRR value (95%CI)P-value
Clinical stage0.6700.2368.08001.955 (1.230-3.103)0.004
Differentiation type0.1760.2010.77101.193 (0.805-1.769)0.380
Lymph node metastasis0.7600.23210.7250.468 (0.297-0.737)0.001
Vascular invasion1.0610.22023.3300.346 (0.225-0.532)0.000
TNM0.5190.2295.13600.637 (0.406-0.999)0.049
NOX20.8240.23612.1530.439 (0.276-0.697)0.000